Pharmacological treatment of Parkinson disease: a review.
Identifieur interne : 005609 ( Main/Exploration ); précédent : 005608; suivant : 005610Pharmacological treatment of Parkinson disease: a review.
Auteurs : Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada]Source :
- JAMA [ 1538-3598 ]
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antiparkinson Agents.
- chemical , therapeutic use : Antidepressive Agents, Antiparkinson Agents.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- Humans.
Abstract
Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.
DOI: 10.1001/jama.2014.3654
PubMed: 24756517
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000764
- to stream PubMed, to step Curation: 000764
- to stream PubMed, to step Checkpoint: 000764
- to stream Ncbi, to step Merge: 001734
- to stream Ncbi, to step Curation: 001734
- to stream Ncbi, to step Checkpoint: 001734
- to stream Main, to step Merge: 006026
- to stream Main, to step Curation: 005609
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacological treatment of Parkinson disease: a review.</title><author><name sortKey="Connolly, Barbara S" sort="Connolly, Barbara S" uniqKey="Connolly B" first="Barbara S" last="Connolly">Barbara S. Connolly</name><affiliation wicri:level="4"><nlm:affiliation>Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hamilton Health Sciences, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name><affiliation wicri:level="4"><nlm:affiliation>Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Ontario, Canada3Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Ontario, Canada3Division of Neurology, Department of Medicine, University of Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2014 Apr 23-30</MedlineDate></PubDate></date><idno type="RBID">pubmed:24756517</idno><idno type="pmid">24756517</idno><idno type="doi">10.1001/jama.2014.3654</idno><idno type="wicri:Area/PubMed/Corpus">000764</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000764</idno><idno type="wicri:Area/PubMed/Curation">000764</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000764</idno><idno type="wicri:Area/PubMed/Checkpoint">000764</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000764</idno><idno type="wicri:Area/Ncbi/Merge">001734</idno><idno type="wicri:Area/Ncbi/Curation">001734</idno><idno type="wicri:Area/Ncbi/Checkpoint">001734</idno><idno type="wicri:Area/Main/Merge">006026</idno><idno type="wicri:Area/Main/Curation">005609</idno><idno type="wicri:Area/Main/Exploration">005609</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pharmacological treatment of Parkinson disease: a review.</title><author><name sortKey="Connolly, Barbara S" sort="Connolly, Barbara S" uniqKey="Connolly B" first="Barbara S" last="Connolly">Barbara S. Connolly</name><affiliation wicri:level="4"><nlm:affiliation>Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hamilton Health Sciences, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name><affiliation wicri:level="4"><nlm:affiliation>Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Ontario, Canada3Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Ontario, Canada3Division of Neurology, Department of Medicine, University of Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><series><title level="j">JAMA</title><idno type="eISSN">1538-3598</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antidepressive Agents (therapeutic use)</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Humans</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antidepressive Agents</term><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Hamilton (Ontario)</li><li>Toronto</li></settlement><orgName><li>Université McMaster</li><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Connolly, Barbara S" sort="Connolly, Barbara S" uniqKey="Connolly B" first="Barbara S" last="Connolly">Barbara S. Connolly</name></region><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005609 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005609 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24756517
|texte= Pharmacological treatment of Parkinson disease: a review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24756517" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |